Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$457,328,271
+$85,116,973 QoQ
Shares Held
1,817,391
+6.2% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#88
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2026CallValue
$282,737
CallShares
1,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. ABBV ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,328,271 | 1,817,391 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $372,211,298 | 1,711,395 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $282,737 | 1,300 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $339,981,467 | 1,487,949 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $341,483,527 | 1,474,836 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $266,648,141 | 1,436,527 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $290,180,171 | 1,384,976 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $230,174,276 | 1,295,297 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $242,676,260 | 1,228,865 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $200,294,366 | 1,167,761 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $168,676,316 | 926,284 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $148,982,579 | 961,364 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $126,777,765 | 850,515 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $108,781,540 | 807,404 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $118,432,787 | 743,131 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $112,468,600 | 695,926 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $88,798,838 | 661,641 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $86,296,623 | 563,441 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $79,537,488 | 490,639 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $62,020,105 | 458,051 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $43,872,131 | 406,713 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $38,314,721 | 340,152 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $34,805,283 | 321,616 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,678,973 | 286,318 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,628,190 | 269,759 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $27,244,655 | 277,497 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $18,534,055 | 243,261 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||